It also supports DC maturation, thereby improving antigen presentation and activating adaptive immune responses (18, 22, 23); IFN-α induces tumor cell apoptosis and boosts the cytotoxic functions of NK and T cells, suppressing tumor growth and proliferation (18, 22, 23); CXC chemokine ligand 10 (CXCL10) and other chemokines guide OV-activated effector T cells to the tumor site, enhancing immune infiltration and antitumor activity (18). The gene discussed is IFNA1; the disease is neoplasm.